{ "company_number": "08489630", "name": "Brago Pharmaceuticals Limited", "url": "/company/08489630", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2013-04-15", "dissolved_on": null, "sic_codes": [ { "code": "46450", "description": "Wholesale of perfume and cosmetics", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/46450" }, { "code": "46460", "description": "Wholesale of pharmaceutical goods", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/46460" }, { "code": "46499", "description": "Wholesale of household goods (other than musical instruments) n.e.c", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/46499" }, { "code": "47990", "description": "Other retail sale not in stores, stalls or markets", "section": "G", "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles", "url": "/sic/47990" } ], "registered_address": { "id": 2590863, "url": "/address/2590863", "line1": "UNIT 6", "line2": "NATHAN WAY", "post_town": "LONDON", "county": "", "country": "ENGLAND", "postcode": "SE28 0AQ" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/08489630", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-01-31", "last_made_up": "2025-04-30", "category": "MICRO ENTITY", "filings": [ { "url": "/company/08489630/accounts/2025-04-30", "pdf_url": "/company/08489630/accounts/2025-04-30.pdf", "made_up_date": "2025-04-30", "period_start": "2025-04-30", "period_end": "2025-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "10865.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "113677.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "101451.00", "total_assets_less_current_liabilities": "112316.00", "net_assets_liabilities": "66484.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "66484.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2026.zip" }, { "url": "/company/08489630/accounts/2024-04-30", "pdf_url": "/company/08489630/accounts/2024-04-30.pdf", "made_up_date": "2024-04-30", "period_start": "2024-04-30", "period_end": "2024-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "14500.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "141270.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "98140.00", "total_assets_less_current_liabilities": "112640.00", "net_assets_liabilities": "57327.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "57327.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2025.zip" }, { "url": "/company/08489630/accounts/2023-04-30", "pdf_url": "/company/08489630/accounts/2023-04-30.pdf", "made_up_date": "2023-04-30", "period_start": "2023-04-30", "period_end": "2023-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "19318.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "126134.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "87625.00", "total_assets_less_current_liabilities": "106943.00", "net_assets_liabilities": "44190.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "44190.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2023.zip" }, { "url": "/company/08489630/accounts/2022-04-30", "pdf_url": "/company/08489630/accounts/2022-04-30.pdf", "made_up_date": "2022-04-30", "period_start": "2022-04-30", "period_end": "2022-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "28532.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "84650.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "80290.00", "total_assets_less_current_liabilities": "108822.00", "net_assets_liabilities": "35085.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "35085.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2023.zip" }, { "url": "/company/08489630/accounts/2021-04-30", "pdf_url": "/company/08489630/accounts/2021-04-30.pdf", "made_up_date": "2021-04-30", "period_start": "2021-04-30", "period_end": "2021-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "49943.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "122714.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "57788.00", "total_assets_less_current_liabilities": "107731.00", "net_assets_liabilities": "56981.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "56981.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2021.zip" }, { "url": "/company/08489630/accounts/2020-04-30", "pdf_url": "/company/08489630/accounts/2020-04-30.pdf", "made_up_date": "2020-04-30", "period_start": "2020-04-30", "period_end": "2020-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "52716.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "63883.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4871.00", "total_assets_less_current_liabilities": "57587.00", "net_assets_liabilities": "52786.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "52786.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2020.zip" }, { "url": "/company/08489630/accounts/2019-04-30", "pdf_url": "/company/08489630/accounts/2019-04-30.pdf", "made_up_date": "2019-04-30", "period_start": "2019-04-30", "period_end": "2019-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "39971.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "44538.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "12819.00", "total_assets_less_current_liabilities": "52790.00", "net_assets_liabilities": "42586.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "42586.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2020.zip" }, { "url": "/company/08489630/accounts/2018-04-30", "pdf_url": "/company/08489630/accounts/2018-04-30.pdf", "made_up_date": "2018-04-30", "period_start": "2018-04-30", "period_end": "2018-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "22570.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "50738.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "2917.00", "total_assets_less_current_liabilities": "25487.00", "net_assets_liabilities": "10080.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "10080.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2018.zip" }, { "url": "/company/08489630/accounts/2017-04-30", "pdf_url": "/company/08489630/accounts/2017-04-30.pdf", "made_up_date": "2017-04-30", "period_start": "2017-04-30", "period_end": "2017-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "3900.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "59368.00", "creditors_due_within_one_year": "62122.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-2754.00", "total_assets_less_current_liabilities": "1146.00", "net_assets_liabilities": "546.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "545.00", "shareholder_funds": "546.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2018.zip" }, { "url": "/company/08489630/accounts/2016-04-30", "pdf_url": "/company/08489630/accounts/2016-04-30.pdf", "made_up_date": "2016-04-30", "period_start": "2016-04-30", "period_end": "2016-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "6600.00", "debtors": "24398.00", "cash_bank_in_hand": "4687.00", "current_assets": "43585.00", "creditors_due_within_one_year": "43782.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-197.00", "total_assets_less_current_liabilities": "6403.00", "net_assets_liabilities": "5803.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "5802.00", "shareholder_funds": "5803.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2017.zip" }, { "url": "/company/08489630/accounts/2015-04-30", "pdf_url": "/company/08489630/accounts/2015-04-30.pdf", "made_up_date": "2015-04-30", "period_start": "2015-04-30", "period_end": "2015-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "33141.00", "cash_bank_in_hand": "2997.00", "current_assets": "44852.00", "creditors_due_within_one_year": "24814.00", "creditors_due_after_one_year": "7893.00", "net_current_assets_liabilities": "20038.00", "total_assets_less_current_liabilities": "20039.00", "net_assets_liabilities": "12146.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "12145.00", "shareholder_funds": "12146.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2016.zip" }, { "url": "/company/08489630/accounts/2014-04-30", "pdf_url": "/company/08489630/accounts/2014-04-30.pdf", "made_up_date": "2014-04-30", "period_start": "2014-04-30", "period_end": "2014-04-30", "entity_name": "Brago Pharmaceuticals Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": "18255.00", "creditors_due_within_one_year": "23512.00", "creditors_due_after_one_year": "0.00", "net_current_assets_liabilities": "-5257.00", "total_assets_less_current_liabilities": "-5257.00", "net_assets_liabilities": "-5257.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-5257.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2014.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/08489630/filing-history" }, "confirmation_statement": { "next_due": "2026-09-14", "last_made_up": "2025-08-31" }, "officers": [], "psc": [ { "name": "Mr Mattew Brobbey", "kind": "individual-person-with-significant-control", "person_url": "/person/3217263", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent" ], "notified_on": "2016-05-01", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Matthew Brobbey", "kind": "individual-person-with-significant-control", "person_url": "/person/3220955", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2016-04-12", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:50:00.959197+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }